Queen Mary University of London

126 inventions

Anti-Integrin aVb3 [23C6]

Invented at Queen Mary University of London

FACS IHC IP Fn

Antigen/Gene or Protein Targets: Integrin alpha V ß3 (CD51/61; Osteoclast Functional Antigen)

0 reviews 10 references 1 supplier

Anti-BCRABL [4C12]

Invented at Queen Mary University of London

IHC IF RIA

Antigen/Gene or Protein Targets: BCRABL

0 reviews 6 references 1 supplier

Anti-HLADR [LHM 4]

Invented at Queen Mary University of London

IHC IP WB

Antigen/Gene or Protein Targets: Human Leukocyte Antigen DR

0 reviews 2 references 1 supplier

Anti-MCSP [LHM 2]

Invented at Queen Mary University of London

FACS IHC IF IP WB ICC

Antigen/Gene or Protein Targets: Melanoma associated Chondroitin Sulphate Proteoglycan (MCSP or NG2)

0 reviews 10 references 1 supplier

Anti-Keratin14 [LL001]

Invented by Prof Irene Leigh at Queen Mary University of London

IHC IF IP WB

Antigen/Gene or Protein Targets: Keratin 14

0 reviews 10 references 1 supplier

Anti-Keratin7 [LP1K]

Invented by Prof Birgit Lane at Queen Mary University of London

IHC IF WB

Antigen/Gene or Protein Targets: Keratin 7

0 reviews 11 references 1 supplier

Anti-Keratin7 [LP5K]

Invented by Prof Birgit Lane at Queen Mary University of London

FACS IHC IF WB

Antigen/Gene or Protein Targets: Keratin 7

0 reviews 7 references 1 supplier

Anti-Mast Cell [MCG35]

Invented at Queen Mary University of London

IHC

Antigen/Gene or Protein Targets: Mast cell marker

0 reviews 4 references 1 supplier

Anti-Integrin b1 [4B7]

Invented at Queen Mary University of London

FACS IHC IF IP Fn

Antigen/Gene or Protein Targets: Integrin ß1 (CD29)

0 reviews 2 references 1 supplier

Anti-AF10 [HAF10 10D3/8]

Invented at Queen Mary University of London

ELISA IHC IP WB

Antigen/Gene or Protein Targets: AF10

0 reviews Add a reference 1 supplier

Page 1 of 13

Next Last

75 reagents managed

Anti-Integrin aVb3 [23C6]

Invented at Queen Mary University of London

FACS IHC IP Fn

Antigen/Gene or Protein Targets: Integrin alpha V ß3 (CD51/61; Osteoclast Functional Antigen)

0 reviews 10 references 1 supplier

Anti-CD45R [351C5]

Invented at Imperial Cancer Research Fund Medical Oncology Unit

FACS IHC IF IP WB

Antigen/Gene or Protein Targets: Protein tyrosine phosphatase, receptor type, C (PTPRC, CD45R)

0 reviews 6 references 1 supplier

Anti-BCRABL [4C12]

Invented at Queen Mary University of London

IHC IF RIA

Antigen/Gene or Protein Targets: BCRABL

0 reviews 6 references 1 supplier

Anti-Macrophage marker [5/9]

Invented at Queen Mary University of London

IHC

Antigen/Gene or Protein Targets: Macrophage marker

0 reviews 2 references 1 supplier

Anti-BCRABL [7c6]

Invented at Queen Mary University of London

IF IP WB

Antigen/Gene or Protein Targets: BCRABL

0 reviews 7 references 1 supplier

Anti-Integrin b3 [F11]

Invented at Queen Mary University of London

FACS IHC IP Fn

Antigen/Gene or Protein Targets: Integrin ß3 (CD61)

0 reviews 10 references 1 supplier

Anti-Keratin10 [LH2]

Invented by Prof Irene Leigh at Queen Mary University of London

FACS IHC IF IP WB

Antigen/Gene or Protein Targets: Keratin 10

0 reviews 6 references 1 supplier

Anti-Keratin5 & 14 [LH8]

Invented by Prof Irene Leigh at Queen Mary University of London

IHC IF

Antigen/Gene or Protein Targets: Keratin 5 & 14

0 reviews 3 references 1 supplier

Anti-HLADR [LHM 4]

Invented at Queen Mary University of London

IHC IP WB

Antigen/Gene or Protein Targets: Human Leukocyte Antigen DR

0 reviews 2 references 1 supplier

Anti-MCSP [LHM 2]

Invented at Queen Mary University of London

FACS IHC IF IP WB ICC

Antigen/Gene or Protein Targets: Melanoma associated Chondroitin Sulphate Proteoglycan (MCSP or NG2)

0 reviews 10 references 1 supplier

Page 1 of 8

Next Last

8 members

Queen Mary University of London

126 inventions

75 reagents managed

8 members

How we use cookies